Airway hyperresponsiveness to bronchoconstrictor agonists and hyporesponsiveness to bronchodilator beta-agonists are characteristic features of human asthma. Current evidence favors a causal link between the airway inflammation and altered airway responsiveness of asthma. Cytokines released in the asthmatic airway may provide this link. These cytokines not only have the capacity to modulate the complement and level of activation of immune/inflammatory cells in the airways, but also appear to alter airway responses to agonists. For example, each of the """"""""pro- asthmatic"""""""" cytokines IL-1beta, TNFalpha, IL-2, IL-4, and IL-5, proposed for study, is present in increased quantities in the asthmatic airway and has been shown to result in airway hyperresponsivemness in animals in vivo. It is our hypothesis that these cytokines have direct effects on airway smooth muscle responses resulting in decreased responses to dilator stimuli and increased responses to contractile stimuli. We propose to examine this hypothesis and to determine the mechanism of action of these cytokines using human airway smooth muscle (HASM) cells in culture. A novel technique, magnetic twisting cytometry, that provides a mechanical index of smooth muscle response, cytoskeletal stiffness, will be combined with measurements of Ca++ or cAMP, providing a system that allows for determination of the site in the pathway leading from receptor activation to smooth muscle contraction/relaxation that may be altered by cytokines. A culture system also allows for generation of sufficient quantities of functional cells with which to perform biochemical or molecular biological analyses in order to further examine the mechanism of action of cytokines.
Four specific aims will be pursued; 1) Measure the dose and time related effects of """"""""pro-asthmatic"""""""" cytokines on HASM cell stiffness and cAMP formation in response to isoproterenol and prostaglandin E2 (PGE2); 2) Test the hypothesis that cytokines decrease beta-adrenergic responses by increasing prostaglandin G/H synthase (PGHS) expression leading to increased PGE2 formation, EP3 prostanoid receptor activation of G1 and inhibition of adenylyl cyclase by measuring PGHS-2 and Gia expression, and by use of PGHS-2 and Gi inhibitors, and EP3 receptor agonists; 3) Measure the dose and time related effects of """"""""pro-asthmatic"""""""" cytokines on changes in HASM cell stiffness and intracellular calcium induced by agonists believed to be of importance in the asthmatic lesion, namely histamine, acetylcholine, and substance P, and 4) Test the hypothesis that cytokines increase HASM cell stiffness responses to contractile agonists by increasing the activation of phospholipase C (PLC), by measuring IP3 formation by contractile agonists and PLC activity. Demonstration of the role and mechanism of action of cytokines in leading to beta-adrenergic receptor dysfunction may provide new avenues for improvements in the safe and efficacious use of these agents. Demonstration of the role and mechanism of action of cytokines in augmenting airway smooth muscle responses to contractile agonist may allow us to develop new models of intervention to prevent the induciton of airway hyperresponsiveness, and thereby limit the capacity of the airways to narrow during an asthmatic episode.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056383-06
Application #
6433741
Study Section
Project Start
2000-12-01
Project End
2002-08-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
6
Fiscal Year
2001
Total Cost
$225,945
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Baraldo, Simonetta; Faffe, Deborah S; Moore, Paul E et al. (2003) Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am J Physiol Lung Cell Mol Physiol 284:L1093-102
Moore, Paul E; Calder, Mark M; Silverman, Eric S et al. (2003) Effect of dexamethasone on beta2-adrenergic desensitization in airway smooth muscle: role of the ARG19 polymorphism. Chest 123:368S-9S
Storm van's Gravesande, Karin; Wechsler, Michael E; Grasemann, Hartmut et al. (2003) Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med 168:228-31
Shore, Stephanie A; Moore, Paul E (2003) Regulation of beta-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 137:179-95
Levy, Bruce D; De Sanctis, George T; Devchand, Pallavi R et al. (2003) Lipoxins and aspirin-triggered lipoxins in airway responses. Adv Exp Med Biol 525:19-23
Levy, B D; Serhan, C N (2002) Polyisoprenyl phosphates: natural antiinflammatory lipid signals. Cell Mol Life Sci 59:729-41
Deykin, Aaron; Massaro, Anthony F; Drazen, Jeffrey M et al. (2002) Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med 165:1597-601
Levy, Bruce D; De Sanctis, George T; Devchand, Pallavi R et al. (2002) Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8:1018-23
Moore, Paul E; Church, Trudi L; Chism, David D et al. (2002) IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol 282:L847-53
Shore, Stephanie A (2002) Cytokine regulation of beta-adrenergic responses in airway smooth muscle. J Allergy Clin Immunol 110:S255-60

Showing the most recent 10 out of 46 publications